Clinical Trial: Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity

U.S., July 19 -- ClinicalTrials.gov registry received information related to the study (NCT07072000) titled 'Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity' on July 16.

Brief Summary: This is a an open-label, non-inferiority, multicenter, randomized phase III trial aimed to explore the efficacy and safety of shrinking the anterior border of CTV2 in nasopharyngeal carcinoma patients without tumor invasion into the posterior nasal aperture.

Study Start Date: Aug. 01

Study Type: INTERVENTIONAL

Condition: Nasopharyngeal Cancinoma (NPC)

Intervention: RADIATION: standard CTV delineation

The anterior border of CTV2 is delineated at the posterior 1/3 of the nasal cavity.

RADIATION...